Clinical Trials Browser

OTHER × Leiomyosarcoma × cabozantinib × Clear all

NCT04200443 2026-05-01

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Phase 2 Active not recruiting

96 enrolled 15 charts

Leiomyosarcoma, Sarcoma